MOLECULAR BIOLOGY OF P53 IN PROSTATE CANCER
P53 在前列腺癌中的分子生物学
基本信息
- 批准号:6296063
- 负责人:
- 金额:$ 17.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-06-01 至 2000-05-31
- 项目状态:已结题
- 来源:
- 关键词:artificial chromosomes biomarker gene deletion mutation gene expression genetic library genetic mapping genetic markers human genetic material tag human tissue laboratory mouse loss of heterozygosity metastasis molecular cloning molecular oncology neoplasm /cancer classification /staging neoplasm /cancer genetics nucleic acid sequence oncogenes p53 gene /protein prognosis prostate neoplasms transfection tumor suppressor genes
项目摘要
The search for genetic and environmental factors responsible for the
increasing incidence of prostate cancer in our society has been hampered by
a dearth of molecular and genetic markers associated with either initiation
or progression of prostate neoplasia. Recent studies, however, have shown
that at least two prostate tumor suppressor (PTS) genes are likely to be
present on the short arm of chromosome 8 (8p) near the MSR 8p22) and ANK
(8p11-21) loci, respectively, and that these chromosomal regions undergo
loss of heterozygosity (LOH) in at least 50% of clinical prostate cancers.
The long-term goal of this project is to identify and characterize PTS
genes on 8p, as well as to study their respective role(s) in the
development of prostate neoplasia. We will focus initially on 8p22, since
presumptive LOH hotspots in this region have recently been identified.
Many of the resources developed for the 8p22 studies will also be useful
for subsequently mapping the 8p11-21 region. We propose to further
localize PTS genes on 8p by mapping lOH breakpoints in this region from an
additional 150 prostate tumors. As an important part of this effort, we
will clone and map athe genomic sequences on 8p which are deleted most
frequently in prostate cancers using YAC, cosmid, and other large-insert
libraries. As a prelude to this proposal, we have already isolated and
mapped a series of overlapping yeast artificial chromosome (YAC) clones
covering the entire 8p22 region, and we have screened a chromosome-8-
specific cosmid library with the goal of identifying and mapping
approximately 20 cosmid markers spanning 8p22 at approximately 500 kb
intervals. Our ability to rapidly develop a highly successful, large scale
effort in this area has been greatly facilitated by direct access to a
large number of well-characterized human prostate-cancers through the
Baylor College of Medicine SPORE and by access to the core facilities of
the Baylor College of Medicine human Genoma Center. We are requesting
support for five years to; (1) continue our construction of 8p22 and
8p11-21 chromosomal maps including identification of YAC and cosmid markers
spaced at approximately 500 kb intervals throughout both regions; (2)
Prepare DNA, touch preps, and cytospins from approximately 150 prostate
cancer and non-tumor specimens for mapping LOH hotspots identified at 8p22
and 8p11--21; (4) Identify candidate PTS genes which map within these LOH
hotspots by cDNA screening, exon trapping, and biological assays; and (5)
Prepare YAC and cosmid contigs from mouse chromosomal regions systemic with
human 8p22 and 8p11-21. As part of specific aim 3, we will develop a
transfection-based functional assay for identification and confirmation of
PTS genes using large-insert contigs from lOH hotspot regions. After
stable transfection into metastatic rat and mouse prostate carcinoma cell
lines; the inserts carrying functional PTS genes will be identified on the
basis of their ability to suppress metastasis or growth rate after
transplantation into recipient mice. The sensitivity and specificity of
this assay will be evaluated initially using a series of YACs and cosmids
from 17p, some of which carry a functional p.53 gene.
对基因和环境因素的研究导致了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUSSELL M LEBOVITZ其他文献
RUSSELL M LEBOVITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUSSELL M LEBOVITZ', 18)}}的其他基金
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
克雅氏病生化诊断的发展
- 批准号:
9344705 - 财政年份:2016
- 资助金额:
$ 17.47万 - 项目类别:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
克雅氏病生化诊断的发展
- 批准号:
9199717 - 财政年份:2016
- 资助金额:
$ 17.47万 - 项目类别:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
克雅氏病生化诊断的发展
- 批准号:
8670337 - 财政年份:2013
- 资助金额:
$ 17.47万 - 项目类别:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
克雅氏病生化诊断的发展
- 批准号:
8727118 - 财政年份:2013
- 资助金额:
$ 17.47万 - 项目类别:
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
克雅氏病生化诊断的发展
- 批准号:
8316922 - 财政年份:2012
- 资助金额:
$ 17.47万 - 项目类别:
A nanoparticle prognosticator of chemotherapy outcomes
化疗结果的纳米颗粒预测器
- 批准号:
7744580 - 财政年份:2009
- 资助金额:
$ 17.47万 - 项目类别:
NCTX, a novel liposomal CT contrast agent for blood pool imaging
NCTX,一种用于血池成像的新型脂质体 CT 造影剂
- 批准号:
7479688 - 财政年份:2005
- 资助金额:
$ 17.47万 - 项目类别:
NCTX, a novel liposomal CT contrast agent for blood pool imaging
NCTX,一种用于血池成像的新型脂质体 CT 造影剂
- 批准号:
7324954 - 财政年份:2005
- 资助金额:
$ 17.47万 - 项目类别:
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Fellowship
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Collaborative R&D
膵癌腫瘍内線維化に着目した術前化学療法効果予測に関する画像biomarkerの確立
建立预测胰腺癌瘤内纤维化术前化疗效果的影像生物标志物
- 批准号:
24K18824 - 财政年份:2024
- 资助金额:
$ 17.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 17.47万 - 项目类别:
Standard Grant